Pharma Archives - Genetic Digital

If AI Search Cannot See Your UK Pharma Content, What Will It Cite Instead?

Pharma teams often use gated or noindexed content to manage access to UK HCP and patient information. But AI search and answer tools like ChatGPT introduce a new risk: if the correct UK source is not visible, answer engines may cite non-UK or third-party content instead.

Most healthcare website problems start before design begins

Many healthcare, pharma and life sciences website projects start with a sensible ambition: a better-looking, clearer, more useful website. But the real issue often sits further upstream. Before design begins, teams need to understand what the website actually needs to solve for the business, its audiences and the people who have to manage it.

UK pharma’s POM product-information estates are more fragmented than many teams may realise

Genetic Digital’s UK POM Product-Information Estate Benchmark 2026 assessed 100 UK prescription medicine companies and found a market at very different stages of digital maturity. The findings show why product visibility, audience routing, prescribing information access and findability now need more strategic attention from pharma teams.

AI Search Is Talking About Your Life Sciences Brand. Are You Tracking What It Says

AI search is increasingly explaining your brand, therapy area, pipeline or technology before anyone reaches your website, and often without the accuracy, context or governance your own content depends on. This article shows why pharma, biotech and medtech teams now need to track what AI is saying about them, and how a practical AI visibility audit reveals where you appear, where competitors win, and what to fix.

Is your pharma content visible in AI search and is it being surfaced to the right audience?

AI search is changing more than pharma SEO. It is changing how regulated content is found, interpreted and surfaced to different audiences. This article explores why visibility in AI search is now also a governance and audience-control issue, and what regulated teams should check first.

Clicks Don’t Prove Confidence: What Pharma Teams Should Really Be Measuring

Clicks, sessions and conversions still matter, but they rarely reflect how confidence is built in pharma buying journeys. This article explores what life sciences teams should really be measuring when websites are used for evaluation, scrutiny and internal decision-making.